Difference between revisions of "Pracinostat (SB-939)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m (Warner-admin moved page Pracinostat (SB939) to Pracinostat (SB-939) without leaving a redirect)
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
==Mechanism of action==
 
==Mechanism of action==
 
HDAC inhibitor
 
HDAC inhibitor
 
==History of changes in FDA indication==
 
*2/27/2014: Granted FDA orphan drug status for treatment of [[Acute myeloid leukemia | acute myeloid leulemia]].
 
  
 
==Also known as==
 
==Also known as==
*'''Code name:''' SB939
+
*'''Code name:''' SB-939
  
 
[[Category:Drugs]]
 
[[Category:Drugs]]
 
[[Category:Oral medications]]
 
[[Category:Oral medications]]
 
[[Category:Orphan drug]]
 
 
  
 
[[Category:HDAC inhibitors]]
 
[[Category:HDAC inhibitors]]
Line 19: Line 13:
  
 
[[Category:Investigational drugs]]
 
[[Category:Investigational drugs]]
 +
[[Category:Stub]]

Latest revision as of 00:38, 29 July 2023

Mechanism of action

HDAC inhibitor

Also known as

  • Code name: SB-939